SCHEMBL6662672

SCHEMBL6662672

CCC1(CC)C/C(=C/C(C)N)CC(C)(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6662675 1.00
Hydrochloric Acid SCHEMBL3091557 0.98
Hydrochloric Acid SCHEMBL3091542 0.98
SCHEMBL6664205 0.83
Hydrochloric Acid SCHEMBL3092136 0.81
SCHEMBL13846385 0.76
SCHEMBL3091624 0.63 KDM4E (0.37)
SCHEMBL12948585 0.60
SCHEMBL13846383 0.60
SCHEMBL28307728 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1442008-A1 UNSATURATED 1-AMINO-ALKYLCYCLOHEXANE NMDA, 5HT3 AND NEURONAL NICOTINIC RECEPTOR ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2004-08-04 EP claimed
WO-2003040084-A1 UNSATURATED 1-AMINO-ALKYLCYCLOHEXANE NMDA, 5HT3 AND NEURONAL NICOTINIC RECEPTOR ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2003-05-15 WO claimed
US-6828462-B2 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists MERZ PHARMA GMBH & CO. KGAA (DE) 2004-12-07 US disclosed